- Home
- DTCK vs COEP Comparison
DTCK vs COEP Comparison
Compare DTCK & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- COEP
- Stock Information
- Founded
- DTCK 1999
- COEP 2017
- Country
- DTCK Singapore
- COEP United States
- Employees
- DTCK N/A
- COEP N/A
- Industry
- DTCK Farming/Seeds/Milling
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTCK Industrials
- COEP Health Care
- Exchange
- DTCK Nasdaq
- COEP Nasdaq
- Market Cap
- DTCK 25.7M
- COEP 30.5M
- IPO Year
- DTCK 2023
- COEP N/A
- Fundamental
- Price
- DTCK $0.80
- COEP $9.75
- Analyst Decision
- DTCK
- COEP
- Analyst Count
- DTCK 0
- COEP 0
- Target Price
- DTCK N/A
- COEP N/A
- AVG Volume (30 Days)
- DTCK 31.9K
- COEP 42.5K
- Earning Date
- DTCK 11-13-2024
- COEP 05-09-2025
- Dividend Yield
- DTCK N/A
- COEP N/A
- EPS Growth
- DTCK N/A
- COEP N/A
- EPS
- DTCK 0.02
- COEP N/A
- Revenue
- DTCK $159,836,000.00
- COEP N/A
- Revenue This Year
- DTCK N/A
- COEP N/A
- Revenue Next Year
- DTCK N/A
- COEP N/A
- P/E Ratio
- DTCK $39.69
- COEP N/A
- Revenue Growth
- DTCK N/A
- COEP N/A
- 52 Week Low
- DTCK $0.75
- COEP $2.31
- 52 Week High
- DTCK $1.73
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- DTCK 35.43
- COEP 48.46
- Support Level
- DTCK $0.75
- COEP $9.01
- Resistance Level
- DTCK $1.10
- COEP $9.75
- Average True Range (ATR)
- DTCK 0.05
- COEP 0.83
- MACD
- DTCK -0.02
- COEP 0.01
- Stochastic Oscillator
- DTCK 13.26
- COEP 53.80
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.